Log in or Sign up for Free to view tailored content for your specialty!
Obesity News
Dysregulated metabolic pathways in late pregnancy tied to higher type 2 diabetes incidence
SAN ANTONIO — Dysregulated amino and fatty acid metabolism during late pregnancy was tied to elevated incidence of type 2 diabetes among women with a history of gestational diabetes, according to a presentation at ObesityWeek.
‘Obesity is the new hypertension’: The current landscape of pharmacological weight loss
After decades of research, pharmacologic treatment of obesity gained significant traction with the launch of GLP-1 receptor agonists, and several potentially more potent drugs are currently in the pipeline, a speaker reported.
Log in or Sign up for Free to view tailored content for your specialty!
Teens who had bariatric surgery maintain weight loss, diabetes remission 10 years later
A decade after receiving gastric bypass or sleeve gastrectomy as adolescents, many people maintain their weight loss and achieve remission of obesity-related conditions, including diabetes, according to a study.
Adolescent risk factors can predict risk for future cardiovascular events
Childhood BMI, blood pressure and smoking status performed as well as lipid levels in predicting the risk for cardiovascular events in adulthood, according to study findings published in Pediatrics.
Approaches to holistic obesity treatment and identifying healthful behaviors
BOSTON — Behavioral modification with diet and exercise demonstrated similar weight-loss benefits vs. other pharmaceutical and surgical approaches to obesity management, but patients must remain adherent, a speaker reported.
'They're being lied to': Oatzempic and the 'false market' of GLP-1 dupes
Products claiming to work like GLP-1s are popular and misleading, but primary care providers can help their patients avoid potentially dangerous supplements, according to experts.
Dip in bariatric surgeries shows emerging ‘medical options first’ approach to weight loss
The rate of metabolic bariatric surgery decreased from 2022 to 2023, whereas the use of GLP-1 receptor agonists as anti-obesity medications grew over twofold, a research letter showed.
Many people with ultraprocessed food addiction not identified as needing treatment
BOSTON — Addiction to ultraprocessed food may be diagnosed similarly to other substance use disorders, and reducing stigma and tailored treatment are both important to improving cardiometabolic health, a speaker reported.
Expanding access to weight loss drugs could save tens of thousands of lives each year
Expanding access to weight loss medications could save tens of thousands of lives annually, according to an analysis published in PNAS.
Semaglutide linked to reduced risk for Alzheimer’s in patients with diabetes
In patients with type 2 diabetes, semaglutide was associated with a significantly lower risk for an Alzheimer’s disease diagnosis within 3 years compared with other diabetes medications, according to a study published in Alzheimer’s & Dementia.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read